Xtant Medical Holdings, Inc.
XTNTNYSEHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $133.9M | $117.3M | $91.3M | $58.0M | $55.3M | $53.3M |
| Operating income | $7.3M | −$12.1M | −$10.2M | −$6.8M | −$3.9M | −$751,000 |
| Net income | $5.0M | −$16.4M | $660,000 | −$8.5M | −$4.8M | −$7.0M |
| Total assets | $94.1M | $93.8M | $92.6M | $60.2M | $54.7M | $41.5M |
| Total liabilities | $43.2M | $50.9M | $41.3M | $26.1M | $23.8M | $27.0M |
| Equity | $51.0M | $43.0M | $51.3M | $34.2M | $30.9M | $14.5M |
| EPS (diluted) | $0.03 | $-0.12 | $0.01 | $-0.09 | $-0.06 | $-0.25 |
| Shares out. | 139.1M | 130.2M | 108.9M | 87.3M | 77.8M | 13.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 5.4%
- Net margin
- 3.7%
- Return on equity
- 9.8%
- Return on assets
- 5.3%
- Return on capital (ROCE)
- 11.3%
- Liabilities / assets
- 45.9%
- Debt / equity
- 0.85×
- Book value / share
- $0.37
- Revenue growth (YoY)
- 14.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -3.66distress
- Accruals / assets
- −8.0%clean
- Beneish M-Score
- -3.14normal
- Piotroski F-Score
- 8/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 5 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 9, 2017
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Lytton Laurence WPassive (13G)Feb 17, 2026
- Nantahala Capital Management, LlcActivist (13D)Aug 5, 2025
- Orbimed Advisors LlcActivist (13D)Apr 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 19,453 | 1.0 | -72.4% |
| Apr 30, 2026 | 70,535 | 1.0 | +451.9% |
| Apr 15, 2026 | 12,780 | 1.0 | -67.8% |
| Mar 31, 2026 | 39,674 | 1.0 | +71.2% |
| Mar 13, 2026 | 23,175 | 1.0 | +28.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Other material eventMay 13, 2026
- Regulation FD disclosure · Other material eventApr 13, 2026
- Results of operationsMar 31, 2026
- Other material eventMar 2, 2026
- Other material eventJan 16, 2026
- Completed an acquisition or disposition · Debt acceleration / triggering event · Regulation FD disclosureDec 3, 2025
- Results of operationsNov 10, 2025
- Director / officer change · Shareholder voteNov 10, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SDMay 29, 2026
- S-8 POSMay 13, 2026
- S-8 POSMay 13, 2026
- S-8 POSMay 13, 2026
- S-8 POSMay 13, 2026
- 10-QMay 13, 2026
- 8-KMay 13, 2026
- 8-KApr 13, 2026
- 10-KMar 31, 2026
- 8-KMar 31, 2026
- 8-KMar 2, 2026
- 4PRIMARY DOCUMENTFeb 18, 2026
- SCHEDULE 13G/AFeb 17, 2026
- 4PRIMARY DOCUMENTJan 16, 2026
- 8-KJan 16, 2026
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.